Table 1.
Open in new tab

Clinical Profiles of Patients With and Without Endometriosis From Whom Samples Were Collected for the Analysis of Treg Cells in the PB and PF

ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
(n = 21)(n = 15)(n = 24)
Age, mean ± SD, y31.6 ± 11.938.1 ± 6.737.8 ± 8.2
Age range, y20–5227–4621–52
Menstrual cycle
 P/S/M/A5/12/4/04/9/2/010/11/3/0
Revised ASRM staging
 I / II / III / IV0/0/0/011/4/0/00/0/11/13
Ovarian endometrioma
 Unilateral/bilateral0/00/019/5
Distribution of peritoneal lesions
 Red/black/white0/0/06/8/13/8/6
Complaint of dysmenorrhea
 Present/absent0/04/118/16
Distribution of pelvic adhesion
 Filmy/dense/none0/0/210/0/153/9/12
Coexistence of benign disease
 Endometriosis/dermoid cyst/
SCA/MCA/POC0/16/2/1/215/0/0/0/024/0/0/0/0
ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
(n = 21)(n = 15)(n = 24)
Age, mean ± SD, y31.6 ± 11.938.1 ± 6.737.8 ± 8.2
Age range, y20–5227–4621–52
Menstrual cycle
 P/S/M/A5/12/4/04/9/2/010/11/3/0
Revised ASRM staging
 I / II / III / IV0/0/0/011/4/0/00/0/11/13
Ovarian endometrioma
 Unilateral/bilateral0/00/019/5
Distribution of peritoneal lesions
 Red/black/white0/0/06/8/13/8/6
Complaint of dysmenorrhea
 Present/absent0/04/118/16
Distribution of pelvic adhesion
 Filmy/dense/none0/0/210/0/153/9/12
Coexistence of benign disease
 Endometriosis/dermoid cyst/
SCA/MCA/POC0/16/2/1/215/0/0/0/024/0/0/0/0

Data given as number unless otherwise indicated.

Abbreviations: A, amenorrhea; M, menstrual phase; MCA, mucinous cyst adenoma; P, proliferative phase; POC, paraovarian cyst; S, secretory phase; SCA, serous cyst adenoma.

Table 1.
Open in new tab

Clinical Profiles of Patients With and Without Endometriosis From Whom Samples Were Collected for the Analysis of Treg Cells in the PB and PF

ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
(n = 21)(n = 15)(n = 24)
Age, mean ± SD, y31.6 ± 11.938.1 ± 6.737.8 ± 8.2
Age range, y20–5227–4621–52
Menstrual cycle
 P/S/M/A5/12/4/04/9/2/010/11/3/0
Revised ASRM staging
 I / II / III / IV0/0/0/011/4/0/00/0/11/13
Ovarian endometrioma
 Unilateral/bilateral0/00/019/5
Distribution of peritoneal lesions
 Red/black/white0/0/06/8/13/8/6
Complaint of dysmenorrhea
 Present/absent0/04/118/16
Distribution of pelvic adhesion
 Filmy/dense/none0/0/210/0/153/9/12
Coexistence of benign disease
 Endometriosis/dermoid cyst/
SCA/MCA/POC0/16/2/1/215/0/0/0/024/0/0/0/0
ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
(n = 21)(n = 15)(n = 24)
Age, mean ± SD, y31.6 ± 11.938.1 ± 6.737.8 ± 8.2
Age range, y20–5227–4621–52
Menstrual cycle
 P/S/M/A5/12/4/04/9/2/010/11/3/0
Revised ASRM staging
 I / II / III / IV0/0/0/011/4/0/00/0/11/13
Ovarian endometrioma
 Unilateral/bilateral0/00/019/5
Distribution of peritoneal lesions
 Red/black/white0/0/06/8/13/8/6
Complaint of dysmenorrhea
 Present/absent0/04/118/16
Distribution of pelvic adhesion
 Filmy/dense/none0/0/210/0/153/9/12
Coexistence of benign disease
 Endometriosis/dermoid cyst/
SCA/MCA/POC0/16/2/1/215/0/0/0/024/0/0/0/0

Data given as number unless otherwise indicated.

Abbreviations: A, amenorrhea; M, menstrual phase; MCA, mucinous cyst adenoma; P, proliferative phase; POC, paraovarian cyst; S, secretory phase; SCA, serous cyst adenoma.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close